Legal & Ethical Consideration in Marketing, Product Safety & Intellectual PropertyName:Institutional AffiliationIntroductionPharmaCARE is a leading drug manufacturing company in the United States. Two years ago, the company’s research found out that AD23, one of the company’s top selling drugs, might also slow the progression of Alzheimer’s disease. John and his fellow researchers optimized the drug to better deal with the disease. The improved AD23 was produced by CompCARE, a wholly owned compounding pharmacy. The drug was however linked to several deaths. John, on the other hand, has come out to claim that he should be awarded the patent of the AD23 drug. This document will look into the ethical issues concerning the marketing of the new drug, the responsibilities of parties concerned with the regulation of compounding pharmacies, as well as the true owner of the intellectual property. Finally, the document will also look into a recent case involving intellectual property theft, and asses the outcome of the case.Ethical issues relating to PharmaCAREAccording to the Consumer Product and Safety Act (CPSA), manufacturers are required by law to supply product that are safe for the consumers. Failure to adhere to this regulation, the manufacturer risks very